Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China

•Molecular drug susceptibility testing (DST) significantly reduced time to multidrug-resistant tuberculosis (MDR-TB) diagnosis.•Molecular DST contributed to a decreased time to culture conversion and improved treatment outcome.•Molecular DST provided convincing evidence to better guide the MDR-TB tr...

Celý popis

Podrobná bibliografia

Vydané v:	International journal of infectious diseases Ročník 96; s. 390 - 397
Hlavní autori:	Shi, Wenpei, Davies Forsman, Lina, Hu, Yi, Zheng, Xubin, Gao, Yazhou, Li, Xuliang, Jiang, Weili, Bruchfeld, Judith, Diwan, Vinod K., Hoffner, Sven, Xu, Biao
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Canada Elsevier Ltd 01.07.2020 Elsevier
Predmet:	Line probe assay (LPA) Molecular drug susceptibility testing MTBDRplus/MTBDRsl Multidrug-resistant tuberculosis (MDR-TB) Treatment outcome Treatment outcome Molecular drug susceptibility testing MTBDRplus/MTBDRsl Multidrug-resistant tuberculosis (MDR-TB) Line probe assay (LPA) molecular drug susceptibility testing treatment outcome line probe assay (LPA)
ISSN:	1201-9712, 1878-3511, 1878-3511
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!